Pharming PHAR
NASDAQ PHAR
$9.75 -0.23 (-2.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Pharming (PHAR) posted Return on Capital Employed [ROCE] of 1.89% for Q2 2026, up 1.63 percentage points from 0.27% a year earlier but down 1.95 percentage points from the prior quarter.

Analysis

Pharming (PHAR) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Pharming's Return on Capital Employed [ROCE] came in at 7.73%, up 12.01 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -21.54 percentage points (FY2020 to FY2025).
  • In prior years, Pharming's Return on Capital Employed [ROCE] was -4.28% in FY2024 (-2.81 pp), -1.47% in FY2023 (-9.54 pp), 8.07% in FY2022 (+8.07 pp) and 0.00% in FY2021 (-29.27 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -9.38% in Q2 2024 to a high of 20.34% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +3.90 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 12.73 percentage points; the weakest was Q2 2022, with a drop of 59.93 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 3.85% (Q1 2026), 3.40% (Q4 2025) and 3.39% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Pharming 698.17 Mn -131.99 Mn 141.47 Mn 1.89%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.89%
Mar 31, 2026 3.85%
Dec 31, 2025 3.40%
Sep 30, 2025 3.39%
Jun 30, 2025 0.27%
Mar 31, 2025 -6.89%
Dec 31, 2024 -9.33%
Sep 30, 2024 -8.96%
Jun 30, 2024 -9.38%
Mar 31, 2024 -3.26%
Dec 31, 2023 -1.44%
Sep 30, 2023 -4.56%
Jun 30, 2023 -2.98%
Mar 31, 2023 0.48%
Dec 31, 2022 11.87%
Sep 30, 2022 6.99%
Jun 30, 2022 1.25%
Mar 31, 2022 -1.75%
Dec 31, 2021 0.42%
Sep 30, 2021 20.34%
API Access

Pharming Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEY